EXAM 3 - Blood Disorders Flashcards

1
Q

Sickle Cell Anemia

A

Autosomal recessive disorder, manifests with sickle or crescent shaped RBCs. D/T abnormal type of hemoglobin (hemoglobin-S).

High freq. in mediterranean and African populations

1 in 12 African Americans carry gene for SCA, have sickle cell TRAIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sickle Cell characteristics

A

Sickled cells get “sticky” and stick to walls of endothelium

CAUSES SICKLE SHAPE:
Hemoglobin-S can also cause vasodilation, Acid build up, low O2 and high CO2

Exercise/Cold temps can also cause hemoglobin-S to sickle

Trait for Sickle cell - means they are a carrier:

Genotype is: Heterozygous (40% hemoglobin-S)

SCA the disease - then they are Homozygous recessive and 80-90% hemoglobin-S

Greater concentration of Hemoglobin-S, greater the sickle of RBCs

In Utero - Hemogloubin-F (after 5-6 months) replaced by genetic hemoglobin (could be hemoglobin-S, can take drugs to delay this process)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hereditary Patterns

A

NOT sex linked - if one parent has the the disease, the child will have trait regardless.

If one parent has disease and other has trait, 50% chance child will have disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of SCA

A

Lifespan of sickle cell is 15-20days

RBCs with Hemoglobin-S:
rough textured, rigid, elongated crescent shaped RBC

Occurs under conditions of low O2, exercise, dehydration, acidosis, infection (esp. bacterial) stress, anxiety, fever, exposure to cold, high altitudes

Sickle Cells get STUCK and O2 delivery is reduced. Body not getting enough O2.

Process reversible at first, but becomes permanent d/t entrapment by macrophage system of LIVER and SPLEED

Results in hemolytic anemia: increased destruction of RBCs resulting in deficiency of hgb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Manifestations of SCA

A

More jaundiced

Sclera yellow and urine dark from bilirubin

Painful crises - vascular occlusion from obstruction of cells, no O2 getting around!

more likely to occur: where blood flow is slowest (liver and spleen, medulla of kidney)

In tissue with high metabolic rate (brain and muscle)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Manifestations of SCA pt II

A

Hypoxia

Intense pain

Serious bacterial infections d/t inadequate splenic filtering of microorganisms

splenomegaly as spleen removes dead blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis: SCA

A

Infants: Asymptomatic 4-6 months d/t fetal hgb
Newborn screening for Hgb pathies are used to ID high risk individuals

Stained blood smear shows sickled cells

Prenatal testing ID presence of homozygote state of fetus

serial blood tests demonstrate decreased hct, hgb and rbc

hgb electrophoresis is used to ID presence of hgb-S and confirm disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment of SCA

A

Genetic Disease - NO CURE - bandaid approach

Symptomatic - no compound to reduce or stop, no diet, vitamin or iron therapy

Pain relief requires narcotic analgesics

increase hydration

prophylactic antibiotics

HYDROXYUREA (given to babies with hgb-s) increase solubility of hgb-S (makes less likely to sickle)

Transfusions

pneumovax vaccinations

bone marrow transplant

genetic counseling

avoid precipitating factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Complications of SCA

A

Vaso-occlusive events : Tissue infarction, pain and disability

Splenic Sequestration: Hypovolemia, shock, death

Stroke: Weakness, seizures, inability to speak

Aplastic crisis: bone marrow temporality stops erythropoiesis

Avascular necrosis: long bones in leg or arm, hip replacement

Males: priapism - painful prolonged penile erection lasting hours, days, weeks d/t stasis and occlusion, results in impotence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sickle C Disease (another form of SCA)

A

Recessive Autosomal

onset later in life, less severe painful crisis, occur less frequency

50% have episodes of abdominal or musculoskeletal pain before age 10 and moderate anemia

also have increased risk for infection, fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

complications of ANY sickle cell disease

A

Splenomegaly

Cardiomegaly

Acute chest syndrome - atypical pneumonia resulting from pulmonary infarction

Sickle retinopathy - blindness from retinal detachment

decreased vision at 20-30 y/o

during pregnancy - sever bone pain crisis and high incidence of abortions, stillbirths and neonatal deaths.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hemophilia A

A

“Classic Hemophilia” 80%
VS.
Hemophilia B “Christmas Disease” 20%

(determines which CLOTTING FACTOR is affected)

very rare to find affected FEMALE

severity:
Mild - 6-30% normal Factor VIII
Moderate: 2-5% normal factor VIII
Severe: <1% normal factor VIII, these rarely survive childhood, life in pain, immobile, isolated

Hereditary, sex-linked recessive disease resulting in a deficiency of factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hereditary Patterns

A

Males cannot be carriers - bc the trait is on the X chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Manifestations of Hemophilia A

A

Spontaneous of excessive bleeding

  • severe episodes by minor trauma
  • fatal intracranial hemorrhages with minor head bumps
  • deep hematomas, compartment syndrome (bleeding in muscle)
  • hematuria, hematemesis, tarry stools

Classic Manifestations = Hemarthrosis (bleeding in joints)
-joint swelling, pain, degenerative changes, limited ROM, permanent disability esp in elbows, knees, ankles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hemophilia A Diagnostics and Treatment

A

Prolonged PTT (partial thromboplastin time)

measurement of Factor VIII decreased

prenatal testing

TREATMENT:

Factor VIII from fresh frozen plasma concentrate of cryoprecipitate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hemophilia A Complications

A

intracranial hemorrhage

infection with HIV

surgery extremely risky, even dental extractions

Factor VIII > 30% during and until healing occurs

17
Q

Platelets

A

90% of coagulation disorders r/t platelet dysfunctions

(Platelet storage in spleen)

platelets are first line of defense against accidental blood loss

normally circulate for 8-10days then destroyed by macrophages in liver and spleen

at any one time, 1/3 are in slow transit in the spleen and do not figure in the platelet count

18
Q

Platelets Pt II

A

Normal count: 150,000-400,000 cells/ uL (higher if you do not have a spleen)

Stress = release of epinephrine = splenic contraction = release of platelets into circulation

platelet count low in ppl with enlarged spleens d/t increased trapping in slow transit or macrophage destruction

PETECHIAE are classic manifestations of low platelet count d/t loss of normal endothelial plugging (not always bc of hemorrhage)

Spontaneous hemorrhages (severe) are rare unless platelet count is < 20,000

19
Q

Quantitative platelet disorders: Thrombocytopenia

A

Not enough platelets (low count)

Cause:
decreased or defective production in bone marrow

Decrease survival, increased destruction outside the bone marrow caused by underlying disorder

Sequestration - pooling of blood in spleen or increased amount of blood in a limited vascular area

intravascular dilution

blood loss - hemorrhage

20
Q

Idiopathic Thrombocytopenia Purpura

A

Most common type of low count - cause unknown

AUTOIMMUNE process

Spleen becomes site of immunoglobulins against platelets and increased phagocytosis

TWO FORMS:
Acute - post viral Thrombocytopenia (children btwn 2-6)

Chronic - essential of autoimmune Thrombocytopenia usually adults <50 (esp. women age 20-40)

21
Q

Manifestations of Thrombocytopenia

A

Petechiae - small spots of subcutaneous bleeding

Purpura - larger area of subcutaneous bleeding

Ecchymosis (bruise) - area of subcutaneous bleeding, with color changes

Menorrhagia - excessive menstruation

Bleeding - can happen anywhere

22
Q

Quantitative platelet disorders: Thrombocytopenia Pt II

A

In children, usually preceded by viral infection, acute and usually resolves spontaneously

Therapeutic support:

  • platelet transfusions
  • corticosteroids
  • protect from trauma
23
Q

Other causes of Thrombocytopenia

A

Chronic alcoholism
HIV
Radiation

In NEONATE:
maternal drug ingestion
syphilis
viral infection

LIVER CIRRHOSIS - enlarged spleen, bad blood flow

Lymphoma:
Cancer of lymphoid tissue, enlarges spleen 80% oh total platelets trapped in spleen.

Metastatic Cancer:
infiltration of bone marrow

24
Q

Drugs know to decrease platelets

A

Chemotherapy

thiazide diuretics

Gold

ASA

Heparin

Methyldopa

25
Q

Diagnosis of Thrombocytopenia

A

Platelet count < 20,000

mean platelet volume (MPV)

  • size of average platelet
  • bigger means younger, aggregate better

may help provider determine whether to give platelet infusion

Bone marrow
-abundant megakaryocytes

Humoral tests to measure platelet associated IgG levels (non-specific)

26
Q

Treatment of Thrombocytopenia

A

Prednisone for a few months (suppress immune response)

immunosuppressants

Splenectomy if ineffective

immune globulin (preoperatively) (raises count but only temporarily)

27
Q

Quantitative platelet disorders: Thrombocythemia

A

INCREASE in platelets

risk of thrombosis (clot) and clotting in the vasculature

  • stoke
  • MI
  • PE
  • DVT

-DVT with no explanation (THINK CANCER)

28
Q

Causes of Thrombocythemia

A

Iron deficiency anemia

polycythemia vera

Acute stress response (exercise, post partum, trauma, surgery)

Metastatic cancers

Chronic inflammatory disease (RA)

Splenectomized patient

Oral contraceptives esp with smoking

29
Q

Qualitative Platelet Disorders: Thrombocytopathy

A

Normal amount of platelets, but DONT aggregate

CAUSES:
ASA, antihistamines, NSAID

CHRONIC RENAL FAILURE

Due to toxic effects of retained urea inhibiting aggregation

30
Q

Platelet Aggregation STEP 1

A

Happens though some event like injury

with vascular injury, instantaneous accumulation at site

platelets attach to proteins on damaged surface and release SEROTONIN and ADP

Serotonin = vasoconstriction = decreased bleeding

Serotonin, ADP and other chems = transforms slippery discs to stick spheres = platelet plug

Platelets release thromboxane A, attracts MORE platelets to the area

Fibrinogen connects btwn exposed sites in platelets like a bridge , stabilizes plug

31
Q

Coagulation Reactions

A

MAINTAINS VASCULAR INTEGRITY

involve 13 coagulation factors (proteins) activated in domino manner that leads to clotting of blood.

normally coagulation occurs first through extrinsic pathway

extrinsic pathway is activated by trauma to the blood vessel or surrounding tissue

intrinsic pathway begins in the circulation

both pathways merge by activation Factor X in the final common pathway

Factor X is responsible for converting the plasma protein PROTHROMBIN to THROMBIN

Thrombin is the catalyst for conversion of fibrinogen to fibrin resulting in coagulation

32
Q

Disseminated Intravascular Coagulation (DIC)

A

RARE but FATAL

Clotting and hemorrhage occurs in vascular system at the same time

causes small blood vessel blockage, organ tissue damage (necrosis)

Organs affected: kidneys, brains, lungs, pituitary and adrenal gland, GI mucosa

33
Q

Causes DIC

A

Infection (septic, viral fungal protozoal)

obstetric complications (post partum hemorrhage)

neoplastic disease (acute leukemia, metastatic cancer, lymphoma)

disorders that produce necrosis (burns, transplant rejection, liver necrosis)

Other (DKA, PE, SCA, ARDS, Shock, transfusion reaction)

34
Q

Pathophysiology of DIC

A

Coagulation system triggered

excess fibrin formed and trapped and clots

acidosis in blood, no O2 to tissues, organ failure

Fibrinolysis and antithrombotic mechanisms = anticoagulation

platelets and coagulation factors consumed = hemorrhage

35
Q

Diagnosis of DIC

A

PLT < 100,000

Fibrinogen <150 mg/dl

PT> 15 sec

PTT > 60-80sec

Fibrin degradation products > 45 mcg/dl

D-Dimer test is pos when <1.8 dilution

36
Q

Treatment of DIC

A

Prompt treatment of underlying disorder

Active Bleeding = admin of FFP (fresh frozen platelets) , PLT and PRBCs

heparin therapy = controversial bc delicate balance, could go wrong

37
Q

Fibrinolysis: “Clot Busting”

A

Plasminogen

  • present in plasma, plasmin percursor
  • acted upon by activators present in tissues, endo cells and granulocytes which detect presence of clot

Plasmin (fibrinolysin)
-Active enzyme that cleaves fibrin to soluble fragments and turns fibrin monomers to prevent further polymerization

cleared by liver

Urokinases
- protein secreted by kidney cells that directly activates plasminogen

Tissue Plasminogen Activators (TPA)

  • active only in the presence of fibrin
  • used to de-clot a central line
38
Q

Fibrinolytic System

A

Plasminogen

Plasmin

Lysis of fibrin and inactivation of fibrinogen factor I, V and XIII

fibrin degradation products (FDP)

interferes with platelet aggregation and increases time necessary to convert prothrombin to thrombin (inhibition of further clot formation)